The expression of the adenosine pathway markers CD39 and CD73 in salivary gland carcinomas harbors the potential for novel immune checkpoint inhibition

被引:0
作者
Arthur Bauer
Niklas Gebauer
Juliana Knief
Lars Tharun
Nele Arnold
Armin Riecke
Konrad Steinestel
Hanno M. Witte
机构
[1] Federal Armed Forces Hospital Ulm,Department of Hematology and Oncology
[2] Federal Armed Forces Hospital Ulm,Institute of Pathology and Molecular Pathology
[3] University Hospital of Schleswig-Holstein,Department of Hematology and Oncology
[4] Marienkrankenhaus Hamburg,Institute of Pathology
[5] University Hospital of Schleswig-Holstein,Institute of Pathology
[6] Federal Armed Forces Hospital Hamburg,Department of ENT
来源
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词
SGC; CD39; CD73; Adenosine signaling; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3193 / 3208
页数:15
相关论文
共 180 条
[21]  
Wan Y(2019)Abstract 3278: EOS100850 potently restores adenosine A2Areceptor-dependent suppression of T cell function in the adenosine rich tumor microenvironment Cancer Res 70 2245-1284
[22]  
Matei DE(2017)Overview of the 8th edition TNM classification for head and neck cancer Curr Treat Options Oncol 11 48-1773
[23]  
Zhang Y(2010)CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression Cancer Res 65 793-474
[24]  
Zhang B(2017)Update from the 4th edition of the World Health Organization Classification of head and neck tumours: what is new in the 2017 WHO blue book for tumors and tumor-like lesions of the neck and lymph nodes Head Neck Pathol 12 815-118
[25]  
Cohen RB(2014)Prognostic features in mucoepidermoid carcinoma of major salivary glands with emphasis on tumour histologic grading Histopathology 67 1271-3707
[26]  
Delord JP(2011)Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review Lancet Oncol 6 1754-e218
[27]  
Doi T(2018)Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models Cancer Immunol Immunother 9 37-546
[28]  
Cohen EEW(2017)CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-beta-mTOR-HIF-1 signaling in patients with non-small cell lung cancer Oncoimmunology 12 4123-4709
[29]  
Soulieres D(2019)Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity Cancer Discov 36 455-1976
[30]  
Le Tourneau C(2019)CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110beta and predicts poor prognosis J Hematol Oncol 27 109-76